Characteristics of AA patients studied
Age, y/sex . | Type of AA . | Preceding hepatitis . | Blood transfusion . | Immunosuppressive therapy before sampling . |
|---|---|---|---|---|
| Antikinectin IgG antibody-positive | ||||
| 18/F | Moderate | − | − | + |
| 48/M | Severe | + | ±* | − |
| 12/M | Severe | − | + | + |
| 18/F | Moderate | − | + | + |
| 9/M | Moderate/severe | − | + | + |
| 13/M | Severe | − | + | + |
| 57/M | Moderate/severe | − | + | + |
| Antikinectin IgG antibody-negative | ||||
| 3/F | Moderate/severe | − | − | − |
| 15/F | Severe | − | − | − |
| 11/M | Moderate/severe | − | − | + |
| 24/F | Moderate/severe | − | + | − |
| 9/M | Moderate/severe | − | + | + |
| 56/F | Moderate | − | + | − |
| 0/M | Moderate/severe | − | + | − |
| 3/F | Moderate | − | + | + |
| 15/M | Moderate/severe | − | + | + |
| 33/M | Severe | + | + | − |
| 38/M | Moderate/severe | + | + | + |
Age, y/sex . | Type of AA . | Preceding hepatitis . | Blood transfusion . | Immunosuppressive therapy before sampling . |
|---|---|---|---|---|
| Antikinectin IgG antibody-positive | ||||
| 18/F | Moderate | − | − | + |
| 48/M | Severe | + | ±* | − |
| 12/M | Severe | − | + | + |
| 18/F | Moderate | − | + | + |
| 9/M | Moderate/severe | − | + | + |
| 13/M | Severe | − | + | + |
| 57/M | Moderate/severe | − | + | + |
| Antikinectin IgG antibody-negative | ||||
| 3/F | Moderate/severe | − | − | − |
| 15/F | Severe | − | − | − |
| 11/M | Moderate/severe | − | − | + |
| 24/F | Moderate/severe | − | + | − |
| 9/M | Moderate/severe | − | + | + |
| 56/F | Moderate | − | + | − |
| 0/M | Moderate/severe | − | + | − |
| 3/F | Moderate | − | + | + |
| 15/M | Moderate/severe | − | + | + |
| 33/M | Severe | + | + | − |
| 38/M | Moderate/severe | + | + | + |
This patient received his first blood transfusion immediately prior to blood sampling.